Lung Function and Asthma Clinical Control in N-ERD Patients, Three-Year Follow-Up in the Context of Real-World Evidence

References

• White AA, Stevenson DD, Longo DL. Aspirin-exacerbated respiratory disease. N Engl J Med. 2018;379(11):1060–1070. doi:10.1056/nejmra1712125
   PubMed Web of Science ®Google Scholar
• Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135(3):676–681.e1. doi:10.1016/j.jaci.2014.08.020
   PubMed Web of Science ®Google Scholar
• Pavón-Romero GF, Ramírez-Jiménez F, Roldán-Alvarez MA, Terán LM, Falfán-Valencia R. Physiopathology and genetics in aspirin-exacerbated respiratory disease. Exp Lung Res. 2017;43(8):327–335. doi:10.1080/01902148.2017.1358776
   PubMed Web of Science ®Google Scholar
• Scott WC, Cahill KN, Milne GL, et al. Inflammatory heterogeneity in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;147(4):1318–1328.e5. doi:10.1016/j.jaci.2020.11.001
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID ‐Exacerbated Respiratory Disease (N‐ ERD)—a EAACI position paper. Allergy. 2019;74(1):28–39. doi:10.1111/all.13599
   PubMed Web of Science ®Google Scholar
• Li R, Luo F. Safety and efficacy of aspirin desensitization combined with long-term aspirin therapy in aspirin-exacerbated respiratory disease. J Investig Allergol Clin Immunol. 2020;30(5):327–333. doi:10.18176/jiaci.0433
   PubMed Web of Science ®Google Scholar
• Tuttle KL, Buchheit KM, Laidlaw TM, Cahill KN. A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2018;6(3):1045–1047. doi:10.1016/j.jaip.2018.01.038
   PubMed Web of Science ®Google Scholar
• Schatz M, Hsu JWY, Zeiger RS, et al. Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2014;133(6):1549–1556. doi:10.1016/j.jaci.2013.10.006
   PubMed Web of Science ®Google Scholar
• Joppert W, Stillner CA, Cruz VO. Closure of splenic bed after splenectomy in cases of huge splenomegaly. Int Surg. 1979;64(3):61–62.
   PubMed Web of Science ®Google Scholar
• Shin S-W, Park J, Kim Y-J, et al. A highly sensitive and specific genetic marker to diagnose aspirin-exacerbated respiratory disease using a genome-wide association study. DNA Cell Biol. 2012;31(11):1604–1609. doi:10.1089/dna.2012.1688
   PubMed Web of Science ®Google Scholar
• Turpeinen H, Laulajainen-Hongisto A, Lyly A, et al. Lung function and side effects of Aspirin desensitization: a real world study. Eur Clin Respir J. 2021;8(1). doi:10.1080/20018525.2020.1869408
   Web of Science ®Google Scholar
• Makary CA, Holmes T, Unsal A, et al. Long-term role of zileuton in the treatment of chronic rhinosinusitis in aspirin exacerbated respiratory disease. Am J Otolaryngol. 2022;43(1):103227. doi:10.1016/j.amjoto.2021.103227
   PubMed Web of Science ®Google Scholar
• Talat R, Gengler I, Phillips KM, Caradonna DS, Gray ST, Sedaghat AR. Chronic rhinosinusitis outcomes of patients with aspirin-exacerbated respiratory disease treated with budesonide irrigations: a case series. Ann Otol Rhinol Laryngol. 2022;131(10):1130–1136. doi:10.1177/00034894211054948
   PubMed Web of Science ®Google Scholar
• Lal D, Golisch K, Chang YHA, Rank M. Baseline clinical characteristics predict follow-up clinic attendance in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis: clinic attendance after ESS. Int Forum Allergy Rhinol. 2016;6(5):508–513. doi:10.1002/alr.21701
   PubMed Web of Science ®Google Scholar
• Ramírez-Jiménez F, Vázquez-Corona A, Sánchez-de la Vega Reynoso P, et al. Effect of LTRA in L-ASA challenge for aspirin-exacerbated respiratory disease diagnosis. J Allergy Clin Immunol Pract. 2021;9(4):1554–1561. doi:10.1016/j.jaip.2020.10.041
   PubMed Web of Science ®Google Scholar
• Jakiela B, Soja J, Sladek K, et al. Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;147(4):1269–1280. doi:10.1016/j.jaci.2020.08.007
   PubMed Web of Science ®Google Scholar
• Global strategy for asthma management and prevention revised 2014; 2014. Available from: https://ginasthma.org/wp-content/uploads/2019/01/2014-GINA.pdf. Accessed July 20, 2023.
   Google Scholar
• Torre-Bouscoulet L, Pérez-Padilla R. Ajuste de varias ecuaciones de referencia espirométrica a una muestra poblacional en México. Salud Publica Mex. 2006;48(6). doi:10.1590/s0036-36342006000600004
   PubMedGoogle Scholar
• ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J. 2003;22(3):470–477. doi:10.1183/09031936.03.00261903
   PubMed Web of Science ®Google Scholar
• Bochenek G, Szafraniec K, Kuschill-Dziurda J, Nizankowska-Mogilnicka E. Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease. Respir Med. 2015;109(5):588–595. doi:10.1016/j.rmed.2015.02.015
   PubMed Web of Science ®Google Scholar
• Ban GY, Youn DY, Ye YM, Park HS. Increased expression of serine palmitoyl transferase and ORMDL3 polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirin-exacerbated respiratory disease. PLoS One. 2020;15(10):e0240334. doi:10.1371/journal.pone.0240334
   PubMed Web of Science ®Google Scholar
• Park BL, Kim TH, Kim JH, et al. Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. Hum Genet. 2013;132(3):313–321. doi:10.1007/s00439-012-1247-2
   PubMed Web of Science ®Google Scholar
• Pavón-Romero GF, Pérez-Rubio G, Ramírez-Jiménez F, et al. IL10 rs1800872 is associated with non-steroidal anti-inflammatory drugs exacerbated respiratory disease in Mexican-mestizo patients. Biomolecules. 2020;10(1):104. doi:10.3390/biom10010104
   PubMed Web of Science ®Google Scholar
• Kuruvilla ME, Lee FEH, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56(2):219–233. doi:10.1007/s12016-018-8712-1
   PubMed Web of Science ®Google Scholar
• Taniguchi M, Mitsui C, Hayashi H, et al. Aspirin-exacerbated respiratory disease (AERD): current understanding of AERD. Allergol Int. 2019;68(3):289–295. doi:10.1016/j.alit.2019.05.001
   PubMed Web of Science ®Google Scholar
• Vähätalo I, Ilmarinen P, Tuomisto LE, Niemelä O, Kankaanranta H. Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study. Respir Med. 2018;137:70–76. doi:10.1016/j.rmed.2018.02.025
   PubMed Web of Science ®Google Scholar
• Vähätalo I, Kankaanranta H, Tuomisto LE, Niemelä O, Lehtimäki L, Ilmarinen P. Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma. ERJ Open Res. 2021;7(1):00715–02020. doi:10.1183/23120541.00715-2020
   PubMedGoogle Scholar
• Hojo M, Iikura M, Hirashima J, Suzuki M, Sugiyama H. A comparison of long-term anti-inflammatory effect of two ICS/LABA combination inhalers; Fix-dosed maintenance therapy with budesonide/formoterol and salmeterol/fluticasone. Allergol Int. 2014;63(1):103–111. doi:10.2332/allergolint.13-oa-0590
   PubMed Web of Science ®Google Scholar
• Sher LD, Yiu G, Sakov A, Liu S, Caracta CF. Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma. Allergy Asthma Proc. 2017;38(5):343–353. doi:10.2500/aap.2017.38.4069
   PubMed Web of Science ®Google Scholar
• Berges-Gimeno MP, Simon RA, Stevenson DD. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2003;90(3):338–341. doi:10.1016/s1081-1206(10)61803-0
   PubMed Web of Science ®Google Scholar
• Porpodis K, Papakosta D, Manika K, et al. Long-term prognosis of asthma is good—A 12-year follow-up study. Influence of treatment. J Asthma. 2009;46(6):625–631. doi:10.1080/02770900903029796
   PubMed Web of Science ®Google Scholar
• Hough KP, Curtiss ML, Blain TJ, et al. Airway Remodeling in Asthma. Front Med. 2020;7. doi:10.3389/fmed.2020.00191
   Web of Science ®Google Scholar
• Mascia K, Haselkorn T, Deniz YM, Miller DP, Bleecker ER, Borish L. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2005;116(5):970–975. doi:10.1016/j.jaci.2005.08.035
   PubMed Web of Science ®Google Scholar
• Yii ACA, Tan GL, Tan KL, Lapperre TS, Koh MS. Fixed airways obstruction among patients with severe asthma: findings from the Singapore general hospital-severe asthma phenotype study. BMC Pulm Med. 2014;14(1). doi:10.1186/1471-2466-14-19
   PubMedGoogle Scholar
• Lee T, Lee YS, Bae YJ, et al. Smoking, longer disease duration and absence of rhinosinusitis are related to fixed airway obstruction in Koreans with severe asthma: findings from the COREA study. Respir Res. 2011;12(1). doi:10.1186/1465-9921-12-1
   Google Scholar
• Boskabady MH, Rezaeitalab F, Rahimi N, Dehnavi D. Improvement in symptoms and pulmonary function of asthmatic patients due to their treatment according to the Global Strategy for Asthma Management (GINA). BMC Pulm Med. 2008;8(1). doi:10.1186/1471-2466-8-26
   PubMedGoogle Scholar
• Lin J, Fu X, Jiang P, et al. INITIAL – an observational study of disease severity in newly diagnosed asthma patients and initial response following 12 weeks’ treatment. Sci Rep. 2019;9(1). doi:10.1038/s41598-018-36611-w
   Google Scholar
• Stevens WW, Peters AT, Hirsch AG, et al. Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2017;5(4):1061–1070.e3. doi:10.1016/j.jaip.2016.12.027
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim C, Lee E, et al. Long‐term clinical outcomes of aspirin‐exacerbated respiratory disease: real‐world data from an adult asthma cohort. Clin Exp Allergy. 2023. doi:10.1111/cea.14362
   Web of Science ®Google Scholar
• Sears MR. Lung function decline in asthma. Eur Respir J. 2007;30(3):411–413. doi:10.1183/09031936.00080007
   PubMed Web of Science ®Google Scholar
• Jerschow E, Edin ML, Chi Y, et al. Sinus surgery is associated with a decrease in aspirin-induced reaction severity in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2019;7(5):1580–1588. doi:10.1016/j.jaip.2018.12.014
   PubMed Web of Science ®Google Scholar
• Mullur J, Steger CM, Gakpo D, et al. Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2022;128(5):575–582. doi:10.1016/j.anai.2022.01.043
   PubMed Web of Science ®Google Scholar
• Schneider TR, Johns CB, Palumbo ML, Murphy KC, Cahill KN, Laidlaw TM. Dietary fatty acid modification for the treatment of aspirin-exacerbated respiratory disease: a prospective pilot trial. J Allergy Clin Immunol Pract. 2018;6(3):825–831. doi:10.1016/j.jaip.2017.10.011
   PubMed Web of Science ®Google Scholar
• Lindsay JT, Heaney LG. Non-adherence in difficult asthma and advances in detection. Expert Rev Respir Med. 2013;7(6):607–614. doi:10.1586/17476348.2013.842129
   PubMed Web of Science ®Google Scholar
• Schatz M, Zeiger RS, Yang SJ, et al. Change in asthma control over time: predictors and outcomes. J Allergy Clin Immunol Pract. 2014;2(1):59–64. doi:10.1016/j.jaip.2013.07.016
   PubMed Web of Science ®Google Scholar
• Baba K, Hattori T, Yagi T, et al. Adherence with long-term asthma management in patients who experienced hospitalized asthma exacerbation. Allergol Int. 2009;58(2):217–224. doi:10.2332/allergolint.08-oa-0012
   PubMedGoogle Scholar
• Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MCJM, Verhamme KMC. Medication adherence and the risk of severe asthma exacerbations: a systematic review. Eur Respir J. 2015;45(2):396–407. doi:10.1183/09031936.00075614
   PubMed Web of Science ®Google Scholar
• Akan A, Dibek Mısırlıoğlu E, Civelek E, Kocabaş CN. Determining the best tool comparable with global initiative for asthma criteria for assessing pediatric asthma control. Pediatr Allergy Immunol Pulmonol. 2021;34(3):89–96. doi:10.1089/ped.2020.1334
   PubMed Web of Science ®Google Scholar
• Alvarez-Gutiérrez FJ, Medina-Gallardo JF, Pérez-Navarro P, et al. Relación del test de control del asma (ACT) con la función pulmonar, niveles de óxido nítrico exhalado y grados de control según la Iniciativa Global para el Asma (GINA). Arch Bronconeumol. 2010;46(7):370–377. doi:10.1016/j.arbres.2010.04.003
   PubMed Web of Science ®Google Scholar
• Franklin JM, Liaw KL, Iyasu S, Critchlow CW, Dreyer NA. Real‐world evidence to support regulatory decision making: new or expanded medical product indications. Pharmacoepidemiol Drug Saf. 2021;30(6):685–693. doi:10.1002/pds.5222
   PubMed Web of Science ®Google Scholar
• Maissenhaelter BE, Woolmore AL, Schlag PM. Real-world evidence research based on big data: motivation-challenges-success factors. Onkologe. 2018;24(S2):91–98. doi:10.1007/s00761-018-0358-3
   PubMedGoogle Scholar
• Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Interpretation and impact of real-world clinical data for the practicing clinician. Adv Ther. 2018;35(11):1763–1774. doi:10.1007/s12325-018-0805-y
   PubMed Web of Science ®Google Scholar
• Harari S. Randomised controlled trials and real-life studies: two answers for one question. Eur Respir Rev. 2018;27(149):180080. doi:10.1183/16000617.0080-2018
   PubMed Web of Science ®Google Scholar